一种基于单细胞测序和批量转录组分析的结直肠癌的新型阿诺基斯相关基因预后模型
1Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Scientific reports
|August 17, 2025
概括
这项研究确定了10个与阿诺基斯相关的基因,作为结直肠癌 (CRC) 的有希望的预后生物标志物. 这些基因可以帮助分层患者的风险和预测生存结果,帮助个性化治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的全球健康挑战,死亡率高.
- 有效的预后生物标志物对于改善CRC患者的治疗结果和指导治疗决策至关重要.
- 在CRC预后中,基因相关基因 (ANRG) 的作用尚未使用先进的转录组分析进行广泛研究.
研究的目的:
- 为了研究在结直肠癌中与阿诺基斯相关的基因的预后价值.
- 开发一种新的CRC预后模型,该模型基于与阿诺基斯相关的基因表达.
- 为了确定可以预测患者存活的关键阿诺基斯相关基因.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于识别与anoikis相关的差异表达基因 (DEGs).
- 权重基因共同表达网络分析 (WGCNA) 应用于大量RNA测序数据.
- 使用最小绝对收缩和选择操作员 (LASSO) -Cox回归来选择关键预后基因并构建预测模型.
主要成果:
- 一个10基因预后模型 (MGP,TPM2,CRIP2,TUBB6,C1orf54,NOTCH3,LTBP1,CSRP2,FSTL3和VIM) 已经成功开发出来.
- 该模型表现出强大的预测准确性,曲线下的面积 (AUC) 值分别为0.744,0.797和0.755的1年,3年和5年生存期.
- 与阿诺基斯相关的基因被确定为CRC患者存活率的显著预测因素.
结论:
- 与阿诺基斯相关的基因具有作为结直肠癌预后生物标志物的巨大潜力.
- 开发的10基因模型可以根据CRC患者的死亡风险有效地分层.
- 这些发现可能有助于更个性化的CRC风险评估和治疗策略.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.2K
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
